Skip to main content

Advertisement

Log in

Study of autoantibodies in patients with keratoconjunctivitis sicca infected by the human T cell lymphotropic virus type 1

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Human T cell lymphotropic virus type 1 (HTLV-1) is endemic in many regions of the world, including Brazil, and has been associated to several immunological manifestations such as arthritis, uveitis, dermatitis and Sjögren’s syndrome. This study was intended to evaluate the frequency of autoantibodies in patients infected with HTLV-1 and manifesting keratoconjunctivitis sicca (KCS). HTLV-1 patients with KCS, enrolled in a reference ambulatory of the city of Salvador, were tested for autoantibodies such as antinuclear antibodies, rheumatoid factor, anti-SSA/Ro and anti-SSB/La. Two comparison groups were also included: (a) HTLV-1 patients without KCS and (b) seronegative patients with KCS. Correlation of proviral load (PVL) in HTLV-1 patients with presence or absence of KCS was also assessed. No autoantibodies were detected in HTLV-1 patients with KCS. The PVL of HTLV-1 patients was higher in patients with KCS without other clinical manifestations customarily associated to HTLV-1. In conclusion, in this study, no changes were observed in humoral immunity concerning production of certain autoantibodies in HTLV-1-infected patients with KCS, which suggests that other mechanisms may be involved in the pathogenesis of this manifestation. Additionally, PVL may be a marker of KCS development in these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC (1980) Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 77(12):7415–7419

    Article  CAS  PubMed  Google Scholar 

  2. Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL (2005) Global epidemiology of HTLV-I infection and associated diseases. Oncogene 24(39):6058–6068

    Article  CAS  PubMed  Google Scholar 

  3. Galvao-Castro B, Loures L, Rodriques LG et al (1997) Distribution of human T-lymphotropic virus type I among blood donors: a nationwide Brazilian study. Transfusion 37(2):242–243

    Article  CAS  PubMed  Google Scholar 

  4. Dourado I, Alcantara LC, Barreto ML, da Gloria Teixeira M, Galvao-Castro B (2003) HTLV-I in the general population of Salvador, Brazil: a city with African ethnic and sociodemographic characteristics. J Acquir Immune Defic Syndr 34(5):527–531

    Article  PubMed  Google Scholar 

  5. Yoshida M, Miyoshi I, Hinuma Y (1982) Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 79(6):2031–2035

    Article  CAS  PubMed  Google Scholar 

  6. Gessain A, Barin F, Vernant JC et al (1985) Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2(8452):407–410

    Article  CAS  PubMed  Google Scholar 

  7. Nishioka K, Maruyama I, Sato K, Kitajima I, Nakajima Y, Osame M (1989) Chronic inflammatory arthropathy associated with HTLV-I. Lancet 1(8635):441

    Article  CAS  PubMed  Google Scholar 

  8. Ijichi S, Matsuda T, Maruyama I, Ijichi S et al (1990) Arthritis in a human T lymphotropic virus type I (HTLV-I) carrier. Ann Rheum Dis 49(9):718–721

    Article  CAS  PubMed  Google Scholar 

  9. Morgan OS, Rodgers-Johnson P, Mora C, Char G (1989) HTLV-1 and polymyositis in Jamaica. Lancet 2(8673):1184–1187

    Article  CAS  PubMed  Google Scholar 

  10. Eguchi K, Matsuoka N, Ida H et al (1992) Primary Sjogren’s syndrome with antibodies to HTLV-I: clinical and laboratory features. Ann Rheum Dis 51(6):769–776

    Article  CAS  PubMed  Google Scholar 

  11. Terada K, Katamine S, Eguchi K et al (1994) Prevalence of serum and salivary antibodies to HTLV-1 in Sjogren’s syndrome. Lancet 344(8930):1116–1119

    Article  CAS  PubMed  Google Scholar 

  12. Mochizuki M, Watanabe T, Yamaguchi K et al (1992) HTLV-I uveitis: a distinct clinical entity caused by HTLV-I. Jpn J Cancer Res 83(3):236–239

    CAS  PubMed  Google Scholar 

  13. Merle H, Cabre P, Merle S, Gerard M, Smadja D (2001) A description of human T-lymphotropic virus type I-related chronic interstitial keratitis in 20 patients. Am J Ophthalmol 131(3):305–308

    Article  CAS  PubMed  Google Scholar 

  14. Buggage RR, Levy-Clarke GA, Smith JA (2001) New corneal findings in human T-cell lymphotrophic virus type 1 infection. Am J Ophthalmol 131(3):309–313

    Article  CAS  PubMed  Google Scholar 

  15. Merle H, Smadja D, Le Hoang P, Merle H, Smadja D, Le Hoang P et al (1996) Ocular manifestations in patients with HTLV-I associated infection–a clinical study of 93 cases. Jpn J Ophthalmol 40(2):260–270

    CAS  PubMed  Google Scholar 

  16. Merle H, Cabre P, Olindo S, Merle S, Smadja D (2002) Ocular lesions in 200 patients infected by the human T-cell lymphotropic virus type 1 in martinique (French West Indies). Am J Ophthalmol 134(2):190–195

    Article  PubMed  Google Scholar 

  17. Nakamura H, Eguchi K, Nakamura T et al (1997) High prevalence of Sjogren’s syndrome in patients with HTLV-I associated myelopathy. Ann Rheum Dis 56(3):167–172

    Article  CAS  PubMed  Google Scholar 

  18. Vitali C, Bombardieri S, Moutsopoulos HM et al (1996) Assessment of the European classification criteria for Sjogren’s syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjogren’s syndrome. Ann Rheum Dis 55(2):116–121

    Article  CAS  PubMed  Google Scholar 

  19. Dehee A, Cesaire R, Desire N et al (2002) Quantitation of HTLV-I proviral load by a TaqMan real-time PCR assay. J Virol Methods 102(1–2):37–51

    Article  CAS  PubMed  Google Scholar 

  20. Green JE, Hinrichs SH, Vogel J, Jay G (1989) Exocrinopathy resembling Sjogren’s syndrome in HTLV-1 tax transgenic mice. Nature 341(6237):72–74

    Article  CAS  PubMed  Google Scholar 

  21. Hida A, Kawabe Y, Kawakami A et al (1999) HTLV-I associated Sjogren’s syndrome is aetiologically distinct from anti-centromere antibodies positive Sjogren’s syndrome. Ann Rheum Dis 58(5):320–322

    Article  CAS  PubMed  Google Scholar 

  22. Nakamura H, Kawakami A, Tominaga M et al (2000) Relationship between Sjogren’s syndrome and human T-lymphotropic virus type I infection: follow-up study of 83 patients. J Lab Clin Med 135(2):139–144

    Article  CAS  PubMed  Google Scholar 

  23. Chisholm DM, Mason DK (1968) Labial salivary gland biopsy in Sjogren’s disease. J Clin Pathol 21(5):656–660

    Article  CAS  PubMed  Google Scholar 

  24. Merle H, Cabre P, Smadja D, Josset P, Landau M, Vernant JC (1999) Sicca syndrome and HTLV-I-associated myelopathy/tropical spastic paraparesis. Jpn J Ophthalmol 43(6):509–512

    Article  CAS  PubMed  Google Scholar 

  25. Pinheiro SR, Lana-Peixoto MA, Proietti AB et al (1995) HTLV-I associated uveitis, myelopathy, rheumatoid arthritis and Sjogren’s syndrome. Arq Neuropsiquiatr 53(4):777–781

    CAS  PubMed  Google Scholar 

  26. Moraes HV Jr, Branco RL, Pinto CMS, Dantas MM, Fiszman R (1995) HTLV-I e Uveíte. Revista Brasileira de Oftalmologia 54(12):39–42

    Google Scholar 

  27. Pinheiro SR, Martins-Filho AO, Ribas JG et al (2006) Immunologic markers, uveitis, and keratoconjunctivitis sicca associated with human T-cell lymphotropic virus type 1. Am J Ophthalmol 142(5):811–815

    Article  CAS  PubMed  Google Scholar 

  28. Giozza SP, Santos SB, Martinelli M, Porto MA, Muniz AL, Carvalho EM (2008) Salivary and lacrymal gland disorders and HTLV-1 infection. Rev Stomatol Chir Maxillofac 109(3):153–157

    Article  CAS  PubMed  Google Scholar 

  29. Santiago M, Crusoé EQ, Matos AV (2002) Manifestações reumatológicas associadas à infecção pelo HTLV-I. Rev Bras Reumatol 42(5):306–310

    Google Scholar 

  30. Ono A, Mochizuki M, Yamaguchi K, Miyata N, Watanabe T (1995) Increased number of circulating HTLV-1 infected cells in peripheral blood mononuclear cells of HTLV-1 uveitis patients: a quantitative polymerase chain reaction study. Br J Ophthalmol 79(3):270–276

    Article  CAS  PubMed  Google Scholar 

  31. Best I, Adaui V, Verdonck K et al (2006) Proviral load and immune markers associated with human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Peru. Clin Exp Immunol 146(2):226–233

    Article  CAS  PubMed  Google Scholar 

  32. Montanheiro PA, Oliveira AC, Posada-Vergara MP et al (2005) Human T-cell lymphotropic virus type I (HTLV-I) proviral DNA viral load among asymptomatic patients and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis. Braz J Med Biol Res 38(11):1643–1647

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors thank Professor Fernanda Grassi for the excellent suggestions provided during the manuscript preparation. MS received a scholarship from CNPq.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mittermayer B. Santiago.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ferraz-Chaoui, A.K., Atta, A.M., Atta, M.L.S. et al. Study of autoantibodies in patients with keratoconjunctivitis sicca infected by the human T cell lymphotropic virus type 1. Rheumatol Int 30, 775–778 (2010). https://doi.org/10.1007/s00296-009-1066-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-009-1066-5

Keywords

Navigation